NYC Marathon Runners Can Help Raise Funds for Lung Cancer and Mesothelioma Research
Athletic events are becoming more popular as opportunities for foundations and organizations to appeal to the public to help raise money to fund critical research that is still needed to find a cure for many diseases, such as mesothelioma and other types of lung cancer. Team Labrecque: Uniting Against Lung Cancer has joined the effort by offering entries into the November 7, 2010, New York City Marathon to a limited number of runners pledging to raise at least $2,500 for the nation’s top cancer research centers. The goal for the NYC marathon fundraising effort is $250,000.
Uniting Against Lung Cancer (Uniting) and the Thomas G. Labrecque Foundation, both founded nine years ago with the common goal of advancing lung cancer research, recently announced their merger resulting in “the single largest private non-profit source of funding for lung cancer research in the United States.”
Uniting partners with the Canary Foundation: “the nation’s only non-profit organization devoted exclusively to the funding, discovery and development of tests for early cancer detection.” Early detection of mesothelioma, a rare asbestos-related cancer, can positively influence a patient’s survival by increasing treatment options and improving their quality of life while battling the cancer.
Mesothelioma, most commonly found in the outer lining of the lungs, can be treated with surgery, chemotherapy and radiation, but once the disease has reached an advanced stage average survival is often less than one year.
The distribution of the funds raised by Team Lebrecque will be handled by a medical advisory team from the country’s leading thoracic oncology institutions. The money will be allocated to some of the nation’s top cancer research centers. Cancer centers with established mesothelioma treatment programs include Brigham and Women’s Hospital in Boston, the University of Texas M.D. Anderson Cancer Center, and the Memorial Sloan-Kettering Cancer Center of New York.